James E. Wagner Cultivation (JWC) (TSXV:JWCA), a leading licensed cannabis producer, is pleased to announce that on July 23, 2018, it entered into a consulting agreement (the “Agreement”) with leading investor relations firm, First Canadian Capital Corp. (“FCC”), pursuant to which FCC will provide JWC with consulting, investor relations and strategic corporate communications services. JWC anticipates that FCC will assist in increasing awareness of the Corporation within the cannabis industry and public markets.
Under the terms of the Agreement, JWC will pay FCC $6,000 per month for a period of twelve months (for an anticipated total of $72,000). In addition, JWC has granted FCC options to purchase a total of 300,000 common shares in the capital of the Corporation (the “Options”). The Options will vest in accordance with the policies of the TSX Venture Exchange, at an exercise price of $1.15. The Agreement and issuance of Options remain subject to the approval of the TSX Venture Exchange.
George Aizpurua, Vice President of FCC, said: “There are many methods used to produce cannabis under the Access to Cannabis for Medical Purposes Regulations. Consumers, patients, and industry leaders have become familiar with the nuances associated with these methods. JWC, in partnership with Canopy Rivers Corporation, the strategic investment arm of Canopy Growth Corporation, boasts a proprietary growing methodology – GrowthStorm™ which is based on aeroponic technology originally developed by NASA. Having a process that is difficult to replicate is a game changer to this lucrative industry where many of the methods used do not sustain superior plant health, consistent high quality and high potency. The FCC team is beyond excited to have been selected as JWC’s capital markets and investor relations advisors and look forward to carrying the opportunity across North American and international markets.”
Nathan Woodworth, Chief Executive Officer and President of JWC, commented; “With the initiation of an ongoing relationship in investor relations with First Canadian Capital, JWC is pleased to anticipate an increase in our visibility. This is a key moment in cannabis history, and we are proud to be a part of it. We are happy to be working with First Canadian Capital, who we believe are the best candidate to help spread our message of the important and cutting edge work we are doing in this industry.”
About James E. Wagner Cultivation Corporation
JWC’s wholly-owned subsidiary is a Licensed Producer under the Access to Cannabis for Medical Purposes Regulations and JWC is a premium cannabis brand, focusing on producing clean, consistent cannabis. JWC uses an advanced and proprietary aeroponic platform named GrowthStorm™. JWC was founded as a family company and prides itself on its family values. JWC began as a collective of patients and growers under the Marijuana Medical Access Regulations (the precursor to ACMPR). Since its inception, JWC has remained focused on providing the best possible patient experience. JWC’s operations are based in Kitchener, Ontario.
Notice regarding forward-looking statements:
This press release contains statements including forward-looking information for purposes of applicable securities laws (“forward-looking statements”) about JWC and its business and operations which include, among other things, statements regarding JWC and consulting, investor relations and corporate communications services provided by FCC. These statements include estimates and statements that describe the Corporation’s plans, objectives and goals, including increasing the visibility of the Corporation within the cannabis industry and public market. The forward-looking statements can be identified by the use of such words as “anticipated”, “will”, “expected”, “approximately”, “may”, “could”, “would” or similar words and phrases. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results to differ materially from those implied in the forward-looking statements. For example, risks include risks regarding the cannabis industry, economic factors, the equity markets generally, funding and grant related risks and risks associated with growth and competition as well as the risks identified in the Corporation’s Filing Statement available under the Corporation’s profile at www.sedar.com. Although JWC has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release and are based on current assumptions which management believes to be reasonable. The Corporation disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For more information about this release, please contact Nathan Woodworth, the President and Chief Executive Officer of JWC:
Phone: (519) 594-0144 x421
George Aizpurua, Vice President of First Canadian Capital Corp.
Phone: (416) 742-5600
In the evolving rush of mergers and acquisitions (M&A) in the Canadian cannabis market, Canopy Growth (NASDAQ:CGC,TSX:WEED) announced it will acquire The Supreme Cannabis Company (TSX:FIRE,OTCQX:SPRWF) in a deal worth approximately C$435 million.
Meanwhile, a cannabis operator in the US confirmed this week that it will receive a financial boost from a partner to solidify its position in the burgeoning Pennsylvania state market.
The Board of Directors of Aphria Unanimously Recommends Shareholders Vote “For” the Arrangement
Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination
Love Hemp Group PLC (AQSE: LIFE) (OTCQB: WRHLF), one of the UK’s leading CBD and Hemp product suppliers, announces that as part of the equity fundraise announced yesterday, Antony Calamita and Andrew Male, Directors of the Company, subscribed for 285,714 Ordinary Shares and 1,428,571 Ordinary Shares respectively. The subscriptions are at a price of 3.5 pence per ordinary share for a total of £60,000. Following these subscriptions, Antony Calamita is now interested in 54,385,714 Ordinary Shares, representing 8.61% of the Company’s share capital as increased by the fundraising, and Andrew Male is now interested in 6,138,196 Ordinary Shares, representing 0.97% of the Company’s issued share capital as increased by the fundraising
Further, the timetable for receipt of applications under the Broker Option, which was also announced yesterday, has been extended until 5:00 pm 9 April 2021 to capture additional interest which was unable to be completed yesterday.
Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, would like to provide the following dial-in information for the Company’s upcoming Annual and Special Meeting (the “Meeting”) scheduled to be held at 11:00 a.m. Eastern Daylight Time on April 12, 2021. Shareholders and proxyholders may access the Meeting via teleconference by dialing 647-723-3984 or 1-866-365-4406 from Canada or the United States, then entering participation code “8487744” followed by the pound (“#”) sign.
In consideration of the COVID-19 pandemic and the recent restrictions imposed by the Ontario Provincial Government, shareholders and proxyholders will only be able to attend the Meeting via teleconference and will not be permitted to attend the Meeting in person at the address provided on the Notice of Annual and Special Meeting of Shareholders.
Gage Cannabis Announces Exclusive Partnership With Blue River to Bring Award-Winning Cannabis Extracts to Michigan
Gage Growth Corp. (“Gage” or the “Company”) (CSE:GAGE), a leading high-quality craft cannabis brand and operator in Michigan, announced today that it has signed an agreement with Blue River™ Extracts & Terpenes (“Blue River™”) to bring the brand’s award-winning solventless technology and other trademark branded products to the state’s medical patients and cannabis consumers. The Company will have exclusive rights to Blue River™’s premium product offerings in Michigan.